News
09-07-2016, 11:30 AM
Scientists may have unlocked the genetic code that determines why many patients with estrogen receptor-positive breast cancer fail to respond to the widely used drug tamoxifen.
More... (http://www.news-medical.net/news/20160907/Researchers-unlock-genetic-code-that-disrupts-response-to-breast-cancer-therapy.aspx)
More... (http://www.news-medical.net/news/20160907/Researchers-unlock-genetic-code-that-disrupts-response-to-breast-cancer-therapy.aspx)